NCT00831571 2022-04-18
Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
Dana-Farber Cancer Institute
Completed
Dana-Farber Cancer Institute
Peking University Cancer Hospital & Institute
Centre Francois Baclesse
Sun Yat-sen University